Acute myeloid leukaemia, or AML, disrupts the production of healthy blood cells and progresses rapidly, making early and effective treatment critical. Around one-third of patients carry a mutation in a gene called NPM1, one of the most frequently altered genes in this disease. The NPM1 gene provides instructions for a protein that normally resides in the nucleus, the compartment housing the cell’s genetic material. In patients with the mutation, the protein accumulates in the cytoplasm, the surrounding fluid of the cell, and this mislocalisation plays a central role in driving the cancer. Understanding precisely why the protein ends up in the wrong place has therefore been a major goal of leukaemia research.

Until now, most explanations have focused on transport: how the mutated protein shuttles between the nucleus and the cytoplasm. The new study, led by Dr Daniel Booth and Dr Claire Seedhouse at the University of Nottingham’s School of Medicine, shows that this picture is incomplete. Something important happens during cell division itself, when the cell dismantles its nucleus and its chromosomes are exposed in the cytoplasm. The research reveals a previously unknown mechanism that helps explain how the mutation disrupts the normal organisation of proteins inside leukaemia cells.

At the heart of the discovery is the mitotic chromosome periphery, a protective layer that surrounds chromosomes during cell division and has received relatively little scientific attention. Using advanced microscopy, genetic engineering and protein-mapping techniques, the researchers found that healthy NPM1 attaches to this layer during mitosis. This attachment acts like a bookmark: when division is complete and the nucleus re-forms, the protein uses the chromosome surface as a reference point to find its way back to its correct location. In leukaemia cells, this process fails. Dr Booth described the chromosome surface as a temporary docking station that helps proteins return to the right place after a cell divides, and noted that in leukaemia cells this docking does not work properly.

The mutated NPM1 protein behaves in two distinct abnormal ways. It fails to attach properly to the chromosome periphery, instead forming abnormal clusters or dispersing throughout the cell. Worse still, the mutant protein actively interferes with the healthy NPM1 protein produced by the normal copy of the gene, further disrupting its ability to return to the right place after division. Together, these findings reveal two previously unrecognised ways in which cell division contributes to the abnormal positioning of NPM1 in leukaemia, adding a new dimension to a problem that researchers had largely framed as one of transport between cellular compartments.

Perhaps the most exciting aspect of the study is that the researchers showed the process could be partially restored in laboratory experiments. By increasing levels of Ki-67, a protein that helps organise the chromosome periphery, the team created a thicker protective layer around the chromosomes. This improved the attachment of mutant NPM1 to the chromosomes in laboratory-grown leukaemia cells, helping to restore its correct positioning and the normal organisation of the cell. The result suggests that manipulating the chromosome periphery could, in principle, correct one of the fundamental defects that sustains the disease.

The involvement of Ki-67 adds a surprising twist. The protein is widely used in clinics as a marker of cell proliferation and is generally associated with more aggressive cancers, so one might expect higher Ki-67 levels to signal a worse prognosis. However, when the team analysed publicly available patient data, a more complex picture emerged: among patients with this particular form of AML, higher Ki-67 levels showed an unexpected trend towards better survival. The researchers stress that this observation requires further investigation, but it hints that the protein’s role in organising the chromosome periphery may be more protective than its reputation suggests.

Critically, the team confirmed that the newly identified mechanism occurs in samples taken directly from AML patients, not only in laboratory-grown cells. This strengthens the clinical relevance of the findings and suggests that the defective docking of NPM1 at the chromosome periphery is a genuine feature of the disease in patients rather than an artefact of cell culture. Dr Seedhouse said that what is particularly exciting is that the team has shown the process can be improved experimentally, adding that although the work is at an early stage, it reveals a completely new way of thinking about how this form of leukaemia develops and, potentially, how it might be treated.

The discovery challenges the longstanding view that abnormal movement of NPM1 between the nucleus and the cytoplasm is the principal explanation for its mislocalisation. Instead, it identifies interactions between proteins and chromosomes during cell division as another important contributor to the disease. If the findings can be translated into therapies, they would represent a fundamentally new strategy: rather than blocking the mutant protein’s transport, future treatments might aim to strengthen the chromosome periphery so that proteins can find their way home after each cell division. Such an approach could potentially complement existing therapies for AML, a disease in which new treatment options remain urgently needed.

The implications may also extend well beyond leukaemia. The abnormal positioning of proteins inside cells is involved in a range of diseases, and understanding how cells organise their proteins during division could open new avenues of research into other conditions. By uncovering an unexpected link between chromosome biology and blood cancer, the Nottingham team has revealed a new direction for understanding, and potentially treating, diseases driven by misplaced proteins, and has highlighted the mitotic chromosome periphery, long a neglected corner of cell biology, as a promising target for future medicine.

Subject of Research: How the NPM1 mutation disrupts protein positioning at the mitotic chromosome periphery in acute myeloid leukaemia

Article Title: Scientists uncover overlooked mechanism driving aggressive leukemia

Article References: Scientists uncover overlooked mechanism driving aggressive leukemia. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: acute myeloid leukaemia, NPM1, cell division, chromosome periphery, Ki-67, protein mislocalisation, University of Nottingham, blood cancer, mitosis, leukaemia research, Nature, mutation

The research, led by former Stowers Postdoctoral Researcher Subu Ramanathan, Ph.D., now an Assistant Professor at the University of Nebraska Medical Center, under the direction of Stowers Investigator and Graduate School President Matt Gibson, Ph.D., focused on epithelial tissues. These are the tightly organized sheets of cells that cover body surfaces and line internal organs. Epithelia face a fundamental geometric dilemma every time they grow or renew themselves. A dividing cell must produce two daughter cells in a space that previously held only one, within a packed sheet where every cell is in contact with its neighbors. How the tissue accommodates this expansion without losing its architecture has been one of the enduring puzzles of tissue biology.

To watch the process unfold, the team turned to mouse intestinal organoids, miniature lab-grown models of gut tissue that recapitulate the structure of the intestinal lining. The intestine is one of the body’s most rapidly renewing tissues, making it an ideal system for studying how repeated rounds of cell division reshape tissue architecture over time. Crucially, organoids offered something that intact tissue rarely does: an unobstructed view. In most tissues, the basal surface of an epithelial cell, the side facing the underlying support layer, is hidden against neighboring cells or basement membrane. In intestinal organoids, that surface faces outward, giving the researchers an unusually clear window onto cell behavior that is normally difficult or impossible to observe directly.

What Ramanathan saw when he first imaged the basal surface was striking. As cells divided, rosettes formed, flower-like clusters in which neighboring cells converged around the dividing cell, and neighboring cells visibly swapped positions with one another. Across 33 filmed cell divisions, the team documented the same overall sequence of rearrangements, and the live observations matched predictions from a computational model the researchers built alongside the imaging work. Together, the two approaches revealed that the dramatic shape changes cells undergo during mitosis, the process by which one cell splits into two, actively reorganize the surrounding tissue rather than passively accommodating it.

The sequence the researchers uncovered unfolds in distinct stages. As a cell prepares to divide, it first withdraws from the tissue’s basal surface, pulling away from the support layer. That withdrawal opens a temporary gap, and neighboring cells immediately close in, briefly forming the rosette structure. Then, as the two daughter cells reinsert themselves back onto the basal surface, they trigger a second round of rearrangement among the surrounding cells. The geometry of the returning daughters turns out to be the critical variable. Together, the two daughter cells were about 30 percent less circular than the original mother cell, producing a more elongated footprint that directed how neighboring cells reorganized, typically perpendicular to the line where the two daughter cells met.

The division process, as Ramanathan described it, creates a problem, a hole in a packed sheet, and then solves it through the geometry of the returning daughter cells. The shape change is not a side effect of mitosis. It does real work, actively sculpting the packing arrangement of the tissue. This insight emerged only after an initial, simpler hypothesis failed. The neighbor exchanges were not happening at the same time as the rosettes, which told the team their tidy story was incomplete. Ramanathan designed an experiment intended to destroy the hypothesis, and it did, revealing that withdrawal and reinsertion drive distinct parts of the remodeling process rather than a single coupled event.

The decisive experimental test came when researchers used a drug to arrest dividing cells before the daughter cells could return to the basal surface. The result was dramatic: neighbor exchange dropped by 93 percent, even though the rosettes still formed normally. This showed that the two phases of the process, withdrawal and reinsertion, are separable and serve different functions. Withdrawal alone creates the rosette, but it is the physical return of the elongated daughter cells that drives the actual swapping of neighbors. Blocking the second phase leaves the tissue with the gathering but without the reshuffling, demonstrating that mitotic geometry is the engine of the rearrangement.

The implications extend well beyond basic developmental biology. Up to 90 percent of cancer diagnoses in humans are carcinomas, cancers that arise from epithelial cell layers. Understanding how healthy epithelial tissues maintain their organization while adding cells may help researchers understand what goes wrong when abnormal growth disrupts that organization in disease. Gibson noted that the study adds to a growing body of work showing that epithelial proliferation is exquisitely choreographed. A dividing cell does not simply become two cells. Instead, the movements of mitosis create geometric changes that alter the organization of the tissue around it, meaning that cell division can act as a morphogenetic process, directly contributing to tissue form and not just tissue size.

The finding reframes how scientists think about proliferation at the tissue level. Cell division has conventionally been described as a mechanism for increasing cell number, with tissue shape maintained by separate remodeling mechanisms. The new work shows that these two functions are intertwined: the very act of division carries within it the instructions for local reorganization. Ramanathan put it plainly: we tend to think of cell division as simply making two cells from one, but this work shows that division also physically reshapes the tissue around it. Division is not just addition; it is a building process.

Many questions remain open. The researchers now want to understand how the physical properties of the surrounding tissue, including the basement membrane, work together with cell geometry during division, and whether the same rules hold across other growing and regenerating tissues. If the choreography observed in intestinal organoids proves to be a general principle, it could reshape how biologists think about development, wound healing, organ regeneration, and the early steps of tumor formation, all contexts in which tissues must grow while preserving, or losing, their precise architecture. For now, the study offers a striking reminder that one of biology’s most familiar events, the splitting of a single cell into two, is also one of its most elegant acts of structural engineering.

Subject of Research: How mitotic shape changes drive cell-contact rearrangements in proliferating epithelial tissue

Article Title: Stowers Institute scientists discover cell division does more than make new cells. It helps reshape tissues.

Article References: Stowers Institute scientists discover cell division does more than make new cells. It helps reshape tissues.. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: cell division, epithelial tissue, tissue architecture, organoids, mitosis, Current Biology, Stowers Institute, morphogenesis, intestinal lining, cancer research, Stowers, Institute

The core idea behind the work is deceptively simple. Instead of asking a biologist to hand-craft measurements of cell shape, size, texture, or molecular markers, and then feeding those engineered features into a classifier, the team trained their model to learn directly from the pixels of long-term live-cell recordings. The cells were imaged continuously as they responded to chemotherapeutic treatment, generating video sequences that capture the full arc of each cell’s response, from the moment the drug takes effect to the final, unmistakable morphological signature of death or division. By treating each video as a sequence, in much the same way that language models treat sentences as sequences of words, the model could learn which visual patterns over time carry information about what the cell is about to do.

Transformers, the architecture that underlies modern large language models, are built around a mechanism called attention. Rather than processing a sequence strictly step by step, attention allows the model to weigh the relevance of every part of the sequence when making a decision about any given moment. For cell fate prediction, this means the model can, in principle, connect a subtle change in cell rounding at hour two with a dramatic membrane blebbing event at hour ten, learning which combinations of visual cues across the timeline are genuinely predictive. This flexibility is precisely what the authors wanted to exploit, because the timing of fate-relevant signals is not fixed. Some cells commit to death early in the treatment window, while others linger, and the informative moments differ from one trajectory to the next.

The performance figures reported in the study are striking. Trained purely on video, without any predefined morphological or molecular features, the model achieved a balanced accuracy of 0.94 and an F1-score of 0.93 in predicting cell outcomes. Balanced accuracy is a particularly meaningful metric here because cell populations under treatment are typically imbalanced, with dying cells often outnumbering survivors or vice versa, and a naive classifier can look good by simply always guessing the majority class. The F1-score, which harmonizes precision and recall, confirms that the model is not merely flagging the obvious cases but reliably identifying both outcomes. Taken together, these numbers demonstrate something that many in the field had suspected but not formally shown: the video of a cell’s life contains enough information, on its own, to forecast its fate.

Perhaps the most provocative finding concerns timing. If the model were simply reading the final frames of each video, where death or division is visually unmistakable, the prediction task would be trivial and biologically uninteresting. The authors therefore designed attention and masking experiments to probe where in the temporal sequence the predictive signal actually resides. By systematically masking out portions of the input video and observing how performance changed, they showed that reliable predictions are possible up to eight hours before the fate event occurs. In other words, the cell is broadcasting its intentions hours in advance, through visual cues that the human eye may register but not interpret, and the attention-based model can pick up that broadcast from the raw footage.

Equally important is what the masking analysis revealed about the structure of the predictive information. The distribution of fate-relevant signals over time turned out to be distinctly different in mitotic sequences compared with apoptotic ones. Cells heading toward division concentrate their predictive information in patterns tied to the mitotic process itself, while cells destined for apoptosis carry their signal in a different temporal profile, consistent with the gradual morphological deterioration that characterizes programmed cell death. This dissociation matters because it suggests the model is not relying on a single generic shortcut, such as overall cell health, but is instead learning genuinely different decision pathways for different fates, each with its own temporal signature.

The explainability framework developed by the team goes beyond timing. By interrogating which visual features the attention mechanism weighs most heavily, the authors connected the model’s predictions to cell morphology and, notably, to p53 signaling. p53, often called the guardian of the genome, is the master regulator that decides whether a stressed cell repairs its damage, arrests its cell cycle, or initiates apoptosis. The finding that the model’s attention aligns with p53-related cues provides a biological anchor for the machine’s decisions, suggesting that the network has converged on features that reflect real signaling states rather than arbitrary image artifacts. This kind of interpretability is essential if such models are to be trusted in biomedical research, where a black box that performs well but explains nothing offers little scientific value.

The implications for cancer therapy are considerable. Chemotherapy works by pushing cells toward lethal fates, yet resistance frequently emerges not through new mutations but through non-genetic mechanisms: cells rewire their signaling, alter their morphology, and adopt transient states that shield them from the drug. If a model can read the early visual signatures of these non-genetic decisions from live-cell video, it becomes possible to identify, at the population level, which cells are committing to death and which are quietly preparing to survive, and to do so hours before the outcome is legible by conventional means. That kind of early readout could accelerate the screening of drug combinations, allowing researchers to see not just whether a treatment eventually kills cells but when and how the decision is made, and whether a second agent can flip the trajectory of the survivors.

Methodologically, the study also marks a shift in how live-cell imaging data can be used. Historically, extracting insight from time-lapse microscopy required laborious pipelines of cell segmentation, feature engineering, and trajectory analysis, each step introducing assumptions and potential biases. By learning directly from raw sequences, the Transformer approach sidesteps much of that bottleneck and, crucially, can discover predictive features that no human would have thought to measure. The comprehensive explainability framework accompanying the model addresses the standard objection to such end-to-end approaches, showing that the learned representations can be traced back to interpretable temporal and morphological cues rather than remaining opaque.

None of this means the problem of cell fate is solved. The model was trained and evaluated on cancer cell populations under chemotherapeutic treatment, and extending it to other cell types, other drugs, and other fate outcomes will require further validation. Yet the central demonstration stands: an attention-based temporal model can predict cell fate from video alone with high accuracy, can do so hours ahead of the visible event, and can explain itself in terms of morphology and p53 signaling that biologists recognize as meaningful. In making the invisible decision points of individual cells visible, the work opens a window onto the non-genetic logic of cellular life-and-death choices, and offers a template for how deep learning can serve not just as a predictor but as an instrument of biological discovery.

Subject of Research: Deep learning prediction of non-genetic cell fate decisions in cancer cells from live-cell imaging

Article Title: Understanding cell fate decisions with temporal attention

Article References: Bürger, F., Dias Gomes, M., Granada, A. E., Moreau, N., & Bozek, K. (2026). Understanding cell fate decisions with temporal attention. PLOS Computational Biology, 22(10), e1014813. https://doi.org/10.1371/journal.pcbi.1014813

Image Credits: AI Generated

DOI: 10.1371/journal.pcbi.1014813

Keywords: cell fate, deep learning, Transformer, live-cell imaging, apoptosis, mitosis, p53, cancer therapy, chemotherapy, explainability, attention mechanism, computational biology

The research, led by Martin Grundy, Claire Seedhouse and Daniel Booth at the University of Nottingham, focuses on a structure that has long fascinated cell biologists but remained poorly connected to human disease: the mitotic chromosome periphery, or MCP. This is a thin but elaborate layer of proteins and RNA that coats the surface of condensing chromosomes during mitosis. Far from being decorative, the MCP acts as a temporary staging ground for nucleolar components, the machinery that builds ribosomes, which are dismantled when the nucleolus disassembles at the start of cell division. By tethering these factors to chromosome surfaces, the cell ensures they are positioned to reassemble nucleoli rapidly in the newborn daughter nuclei. The Nottingham team set out to map this compartment in unprecedented detail and to ask what happens when a notorious leukaemia mutation interferes with it.

Using a proteomic strategy that captures proteins operating in close physical proximity to Ki-67, the best-characterised scaffold protein of the chromosome periphery, the researchers defined a mitosis-specific Ki-67 interactome. This inventory not only confirmed known residents of the MCP but also identified additional components, expanding the catalogue of factors that crowd around dividing chromosomes. When the team cross-referenced the genes encoding these components against cancer mutation databases, a striking pattern emerged: MCP genes are commonly mutated across tumour types, and among them was nucleophosmin, or NPM1, a protein with a central role in nucleolar structure and function. That observation reframed the chromosome periphery as more than a curiosity of cell division; it positioned it as a compartment whose disruption could plausibly contribute to malignancy.

The significance of NPM1 in this context is hard to overstate. Mutations in the NPM1 gene are the most frequent genetic alteration in acute myeloid leukaemia, an aggressive cancer of the blood-forming tissue that predominantly affects older adults. The leukaemia-specific mutations, collectively termed NPM1c+, insert a short stretch of amino acids that creates a new export signal, driving the protein out of the nucleus and into the cytoplasm. Under the microscope, this mislocalisation is a diagnostic hallmark: instead of staining the nucleoli, NPM1 lights up the cytoplasm of the leukaemic blasts. Clinicians use this cytoplasmic pattern to identify a distinct subclass of AML, one that generally responds well to certain treatments but carries its own risks of relapse. What has remained murky is exactly how the mutant protein sustains its exile from the nucleus across the generations of dividing cells.

Grundy and colleagues demonstrate that the answer lies partly in mitosis itself. They found that NPM1c+ fails to bind adequately to the mitotic chromosome periphery, the very platform that wild-type NPM1 uses to stay anchored near the reforming nuclei. Instead, the mutant protein forms aggregates during cell division, drifting away from the chromosomes and thereby losing its ticket back into the nucleolus when division completes. Live-cell imaging and complementary biochemical assays showed that this failure of MCP loading is not a minor side effect; it represents a genuine mechanistic defect that compounds the export-signal problem created by the mutation. In other words, the mutant protein is not merely evicted from the nucleus once; it is repeatedly denied re-entry every time the cell divides.

The study also uncovered a second, subtler contributor to the mislocalisation puzzle. At the onset of mitosis, the nuclear envelope breaks down and the cell undergoes what the authors describe as de-compartmentalisation: the abrupt mixing of nuclear and cytoplasmic contents that accompanies the loss of the nucleus as a separate compartment. The researchers showed that this mixing allows the formation of multimers containing both wild-type and mutant NPM1, complexes in which the mutant protein can effectively drag its normal counterpart along. These mixed assemblies further hinder the return of NPM1 to the nucleoli of daughter cells, meaning that even cells carrying a single mutant allele can experience a measurable depletion of functional nucleolar NPM1. The finding adds an important layer to the picture: mislocalisation is not a static property of the mutant protein but a dynamic process that exploits the normal chaos of cell division.

To test whether the chromosome periphery could be pushed to work harder, the team increased the expression of Ki-67, effectively enlarging the loading capacity of the MCP scaffold. The result was telling. With more Ki-67 available, a greater fraction of NPM1c+ became tethered to the chromosome periphery during mitosis, and the yield of nucleolar NPM1c+ in the daughter cells rose accordingly. This experiment demonstrates that the mislocalisation of the mutant protein is not an all-or-nothing state but a balance of competing forces, one that can be tipped by modulating the capacity of the chromosome periphery. It also raises the provocative possibility that the MCP, long regarded as a transient and inaccessible structure, could be a legitimate drug target in leukaemia.

The clinical dimension of the study came from an analysis of AML patient data, which revealed a significant interaction between Ki-67 expression levels and NPM1 mutation status in predicting overall survival. Among patients whose leukaemia carried wild-type NPM1, higher Ki-67 expression was associated with an increased hazard of death, consistent with the notion that rapidly cycling cells depend heavily on this mitotic scaffold. Among patients with the NPM1c+ mutation, however, the relationship inverted: higher Ki-67 was associated with a reduced hazard. The authors interpret this in light of their mechanistic findings, suggesting that in mutant cells, greater Ki-67-driven loading of NPM1c+ onto the chromosome periphery may partially restore nucleolar re-entry and, in doing so, temper some of the consequences of mislocalisation. Whatever the precise mechanism, the survival analysis underscores that the chromosome periphery is not merely a laboratory phenomenon but a factor with measurable prognostic weight in a major human cancer.

These findings arrive at a moment of genuine momentum in AML research. Over the past decade, the field has moved from one-size-fits-all chemotherapy towards targeted agents, including inhibitors of mutant IDH enzymes and the liposomal formulation of cytarabine and daunorubicin, yet relapse remains a stubborn problem, and the molecular events that sustain the leukaemic state inside dividing cells are still being mapped. The Nottingham study contributes a piece of that map that is genuinely new: it connects a mitotic structure to one of the defining molecular lesions of the disease, and it does so with a combination of proteomics, live imaging, perturbation experiments and patient survival data that gives the story both mechanistic depth and clinical texture. The work was supported by funding from the Biotechnology and Biological Sciences Research Council, the Royal Society, the Academy of Medical Sciences, the Leverhulme Trust, the Nottinghamshire Leukaemia Appeal and Nottingham Hospitals Charity.

There are, of course, caveats and open questions. The chromosome periphery exists only during the brief window of mitosis, which makes pharmacological intervention conceptually challenging, and the study’s mechanistic experiments were performed largely in cell models whose behaviour may not fully recapitulate the bone marrow environment of a patient. The prognostic interaction between Ki-67 and NPM1 status will need validation in larger, independent cohorts before it can inform clinical decision-making. Yet the conceptual payoff is substantial. The study shows that cancer-relevant phenotypes can arise not only from mutations in genes that regulate growth and survival, but from the failure of mutated proteins to navigate the physical reorganisation of the cell during division. It suggests that the mitotic chromosome periphery, with Ki-67 at its heart, represents an untapped therapeutic surface, and it offers leukaemia researchers a new question to pursue: not just what a mutant protein does in the resting cell, but what happens to it when the cell divides.

Subject of Research: Mechanisms of nucleophosmin mislocalisation during mitosis in acute myeloid leukaemia

Article Title: Ki-67, the chromosome periphery and de-compartmentalisation each contribute to nucleophosmin mislocalisation in acute myeloid leukaemia

Article References: Grundy, M., Woodmancy, P., Lucken, K., Xing, X., Markus, R., Bagia, S., Storr, S., Seedhouse, C. H., & Booth, D. G. (2026). Ki-67, the chromosome periphery and de-compartmentalisation each contribute to nucleophosmin mislocalisation in acute myeloid leukaemia. Nature Communications. https://doi.org/10.1038/s41467-026-78560-3

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78560-3

Keywords: acute myeloid leukaemia, nucleophosmin, NPM1c+, Ki-67, mitotic chromosome periphery, mitosis, nucleolus, de-compartmentalisation, protein mislocalisation, cancer mutations, prognosis, cell division

The research, conducted by scientists at Yangzhou University together with collaborating institutions, addresses a long-standing puzzle in plant cell biology. In animals and fungi, CDC20 is famous as the activator of the anaphase-promoting complex/cyclosome, the ubiquitin ligase that triggers the physical separation of chromosomes. Plants, however, typically carry multiple CDC20 genes, and it has remained unclear whether these copies divide the labor among different division types or whether they act as interchangeable, redundant agents. Because rice possesses three CDC20 genes, it offered an ideal system to test these possibilities directly.

The team used CRISPR/Cas9 genome editing to build a series of rice mutants affecting the three CDC20 genes in different combinations. This allelic-series approach is powerful because it allows researchers to titrate the total amount of functional CDC20 activity in a cell rather than simply asking whether one gene is on or off. When the editors disrupted CDC20 function severely, the consequences were dramatic: gametophytic mitosis—the mitotic divisions that produce the plant’s gametes—was impaired, and the gametophytes died. That lethality demonstrates unambiguously that CDC20 is essential for mitotic progression in rice and that the three genes can substitute for one another in this essential role.

The most revealing results, however, came from mutants that retained enough CDC20 activity for mitosis to proceed normally but failed during meiosis. Two mutant combinations, designated cdc20-triple-1 and cdc20-triple-2, arrested at metaphase I of meiosis and could not enter anaphase I, even though their chromosomes had aligned correctly on the division spindle. In other words, the cell had completed all the visible prerequisites for chromosome separation—proper alignment, proper attachment—yet lacked the CDC20-dependent signal needed to commit to anaphase. This cleanly separates the mechanical events of metaphase from the regulatory trigger that ends it.

A second pair of mutants told a complementary story. The cdc20-triple-3 and cdc20-triple-4 alleles progressed through the first meiotic division without obvious failure but then ran into trouble during the second division, showing abnormal chromosome segregation in meiosis II. The contrast between the two mutant classes reveals that CDC20 activity is not a single all-or-nothing requirement but is needed at distinct stages of meiotic progression, with different thresholds or timing demands at meiosis I and meiosis II. An allelic series, the authors note, is precisely the kind of tool that can expose such stage-specific requirements for an essential regulator that a simple knockout would mask entirely.

To understand how these cell-cycle defects connect to the structural machinery of chromosomes, the researchers examined chromosome cohesion and the dynamics of SGO1, a protein that protects cohesion at the centromeres during meiosis. Cohesion—the molecular glue holding sister chromatids or homologous chromosomes together—must be removed in a strictly ordered sequence for meiosis to succeed, first along chromosome arms at anaphase I and then at the centromeres at anaphase II. The analysis of cohesion and SGO1 behavior in the mutants provided clues to how CDC20-dependent progression through the division cycle is coordinated with the scheduled loss of cohesion, linking the regulatory clock of the cell cycle to the physical architecture of the chromosomes themselves.

Biochemically, the findings fit a well-established framework. CDC20 activates the APC/C, which tags securin and other targets for destruction, thereby releasing separase to cleave cohesin and launch anaphase. The spindle assembly checkpoint monitors kinetochore attachment and holds CDC20 in check until every chromosome is properly bivalent-attached. The rice study extends this canonical picture to a multicellular plant and shows that it operates across both division programs: the same CDC20 machinery that licenses sister-chromatid separation in mitosis also governs the two successive anaphase transitions of meiosis, in which homologous chromosomes and then sister chromatids must be segregated in sequence.

The broader significance lies in plant reproduction. Accurate chromosome segregation is not merely a matter of cellular housekeeping; it underpins fertility, seed formation, and ultimately crop yield. Meiotic failures in rice translate directly into sterile gametes and aborted seed development, so understanding the genetic controls of the metaphase-to-anaphase transition has practical implications for breeding and for synthetic chromosome-engineering approaches that seek to manipulate meiosis in crops. The demonstration that three redundant CDC20 genes sustain both mitosis and meiosis gives researchers a defined genetic target set for such efforts.

The work also contributes to a comparative view of cell-cycle control across eukaryotes. Yeast and animal cells rely on CDC20 and its paralog CDH1 to sequence the metaphase-to-anaphase transition and mitotic exit, and the rice results show that a multicopy CDC20 family performs the equivalent role in a plant lineage, with redundancy buffering the organism against the loss of any single copy. The stage-specific phenotypes of the different mutant combinations suggest that subtle differences in CDC20 dosage or timing can selectively compromise meiosis I or meiosis II while sparing mitosis, hinting at quantitative regulation that future studies can dissect at the level of protein abundance, localization, and checkpoint sensitivity.

Taken together, the study establishes CDC20 as the central regulator of the metaphase-to-anaphase transition in all kinds of cell division in rice, and it showcases the value of a graded CRISPR mutant series for exposing hidden requirements of essential genes. By connecting gametophyte lethality, metaphase I arrest, and meiosis II segregation errors to a single regulatory module—and by tying those phenotypes to chromosome cohesion and SGO1 dynamics—the research provides a coherent mechanistic account of how plants safeguard the genome through every division they undertake, from root-tip mitoses to the meioses that produce the next generation.

Subject of Research: CDC20-mediated control of the metaphase-to-anaphase transition in rice mitosis and meiosis

Article Title: The transitions from metaphase to anaphase in all kinds of cell divisions are mediated by CDC20

Article References: The transitions from metaphase to anaphase in all kinds of cell divisions are mediated by CDC20. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: CDC20, APC/C, anaphase, metaphase, rice, meiosis, mitosis, CRISPR, chromosome segregation, SGO1, cell cycle, plant reproduction

Loss of heterozygosity, or LOH, is a familiar concept in genetics. In a diploid organism, each gene normally exists in two copies, one inherited from each parent. Errors during mitosis, the process by which a cell duplicates and divides, can eliminate one of those copies, either through recombination, chromosome loss or segmental deletion. Previous work had established that mitotic errors alter the allelic composition of a gene roughly a thousand times more often than replication errors produce point mutations. This means that when selection favors the loss of a gene’s function, it will frequently be achieved by discarding the chromosome or chromosomal segment that carries it, rather than by mutating the gene itself. Aneuploidy, the state of having an abnormal number of chromosomes, is found in up to a quarter of newly isolated wild strains of Saccharomyces cerevisiae, a striking testament to how common these events are.

What remained unclear was whether complex rearrangements, those affecting multiple chromosomes at once, accumulate gradually through a series of independent steps or emerge suddenly in coordinated bursts. To find out, the team built an experimental system in which genome rearrangements could be generated de novo and their frequency, triggers, architecture and stability all measured. They compiled a list of 454 yeast genes whose deletion had been shown, in earlier screens using two well-established but distinct methods, one detecting gross chromosomal rearrangements and one detecting chromosome instability, to increase LOH. After accounting for strains that could not be manipulated successfully, 392 diploid deletion strains remained, each carrying a homozygous deletion of a different gene together with two heterozygous marker loci: CAN1 on the left arm of chromosome V and ade2::URA3 in the middle of the right arm of chromosome XV.

The researchers propagated 20 replicate mutation-accumulation cultures of each strain and plated cells onto selective media containing canavanine or 5-fluoroorotic acid, which only cells that had lost the functional allele at the corresponding marker could colonize. These assays yielded robust, strain-specific estimates of the single LOH rate per cell division, with 95 percent confidence limits typically spanning only a narrow range around the central value. A substantial majority of the deletion strains, 68 percent at the CAN1 locus and 82 percent at the URA3 locus, showed higher single LOH rates than the wild-type control, confirming that the mutations compiled from earlier qualitative screens indeed destabilize the genome in quantitative assays. The team then scored how frequently double mutants, resistant to both drugs simultaneously, appeared. Deletion strains varied enormously, and the most unstable strains under double selection were also among the most unstable under single selection, with a Spearman rank correlation of 0.61.

The critical question was whether these double events could be explained as two independent single events occurring in sequence. Because the experimental data alone could not distinguish one-step from two-step origins, the team turned to computer simulations. Using the empirically measured single LOH rates, they modeled mutation accumulation across colony growth, allowing cells to become single mutants at their measured rates and double mutants either sequentially or coincidentally at a rate equal to the product of the two single rates. Even under the deliberately conservative assumption that neither single nor double mutants paid any fitness penalty, an assumption that would maximize the survival and spread of sequentially derived double mutants, the simulated frequencies fell far short of what was observed. When fitness costs of 10 and 20 percent were applied, as is more realistic, the gap widened further. The observed double LOH frequencies exceeded the coincidental predictions by tens or even hundreds of times in the most unstable strains, and after subtracting the predicted sequential component, the residual coincidental events remained 26 times more frequent than expected.

What kinds of cellular defects produce such explosive instability? The answer emerged from Gene Ontology analysis of the deleted genes in the most unstable strains. Nearly half of the genes carry annotations related to cell cycle checkpoints, the surveillance mechanisms that halt progression through the division cycle when DNA is damaged or the mitotic spindle is improperly assembled. The checkpoint category as a whole is assigned to only 1.3 percent of all yeast genes, so its dominance among the strongest mutators is statistically striking. The remaining genes in the set are involved in DNA maintenance and repair, sister chromatid cohesion, and spindle formation, processes whose failure can generate damage so extensive that even intact checkpoints cannot contain it. The message is clear: genomes are most vulnerable to complex, multi-chromosome rearrangements when the checkpoints that police DNA integrity and spindle function fail to stop the cell cycle.

Direct examination of the double mutants themselves confirmed the picture. Flow cytometry of roughly 80 independent mutants from each of 43 highly unstable deletion strains revealed that DNA content was often substantially increased or decreased relative to the diploid ancestors, with the variance in DNA content among mutants significantly exceeding that among ancestral replicates. Whole-genome sequencing of mutants from 20 deletion strains went further. The dominant alteration was whole-chromosome aneuploidy, frequently affecting multiple chromosomes beyond the two targeted by selection, with many chromosomes showing non-integer coverage values that indicated mixed populations of cells carrying different chromosome counts. Averaged across all strains and chromosomes, deviations from diploidy appeared in nearly every mutant examined. Crucially, the chromosomes under direct selection, V and XV, showed no more than the average number of changes, evidence that selection at two sites was merely revealing systemic destabilization rather than focused local mutation. Heterozygous point mutations were rare, and the team found essentially no segmental copy number variants, no non-homologous recombination products and no convincing translocations or inversions in non-telomeric regions, despite deliberately validating that their pipelines could detect all such events.

Genetic tests of four particularly unstable strains, deleted for sem1, chl1, mre11 or rad27, provided independent confirmation. When double mutants from these strains were screened for retention of heterozygosity at two additional marker loci on chromosomes II and XII, the frequencies of additional losses were extraordinarily high. In the sem1 background, for example, 16 of 61 double mutants had also lost heterozygosity on chromosome II and 14 on chromosome XII, with 7 losing both, even though such losses normally occur at a rate of only one to a few per ten thousand cell divisions. Triple and quadruple LOH events appeared at frequencies far beyond anything a sequential model could accommodate, reinforcing the conclusion that short periods of hyper-instability, rather than a string of independent accidents, generate these genomes.

The final experiments addressed what happens to these dramatically rearranged genomes over evolutionary time. The team propagated 63 mutant cultures derived from 21 deletion strains for 200 generations in batch culture and re-measured their DNA content. The result was a nearly uniform contraction toward diploidy: strains that started far from two chromosome sets moved markedly closer, and the most divergent isolates showed the greatest fitness gains, growing faster after evolution than before. Aneuploidy, in other words, is typically a transient state, imposed as a cost of rapid adaptation and then pruned by natural selection as faster-growing re-diploidized variants outcompete their unstable relatives. The authors suggest that this ephemerality is exactly why such bursts are so hard to catch in nature, since selection rapidly erases the evidence of a genomic episode.

The findings carry implications well beyond yeast. In free-living microbes, aneuploidy usually slows growth and is quickly eliminated, but it may pay off under multiple stresses, such as exposure to several toxins at once. In the somatic cells of multicellular organisms, the calculus is different. These cells are programmed not to divide, so there is no immediate growth cost to genome restructuring, and a loosening of the brakes on cell division can incidentally expose recessive alleles, a mechanism central to cancer, where the loss of the remaining wild-type copy of a tumor suppressor gene is the classic second hit. The study suggests that failures of cell cycle control may be a common source of the large-scale chromosomal changes that dismantle multiple adaptation barriers during tumor evolution. Complex genome change, on this view, rarely arrives as a leisurely accumulation of small steps; it tends to arrive as a burst, born of a momentarily failing control system, and natural selection then decides what, if anything, survives.

Subject of Research: Loss of heterozygosity and aneuploidy driven by cell cycle control defects in diploid budding yeast

Article Title: Burst of aneuploidy: a cost of adaptation driven by breakdown of cell cycle control

Article References: Pirog, A., Tutaj, H., Tomala, K., & Korona, R. (2026). Burst of aneuploidy: a cost of adaptation driven by breakdown of cell cycle control. Molecular Systems Biology, 22(8), 1292-1311. https://doi.org/10.1038/s44320-026-00217-6

Image Credits: AI Generated

DOI: 10.1038/s44320-026-00217-6

Keywords: aneuploidy, loss of heterozygosity, cell cycle checkpoints, Saccharomyces cerevisiae, genome instability, mitosis, chromosome segregation, DNA repair, mutation rate, experimental evolution, cancer, genome rearrangements

The research, led by Taronish Biayna, Anton Baranovskii and colleagues, provides one of the most detailed portraits yet of how cells manage intron retention, a form of RNA processing control in which an intron, a segment of RNA that is normally spliced out and discarded, is deliberately kept within a mature transcript. Rather than representing a processing error, the study shows that intron retention operates as a genuine regulatory strategy, one that allows cells to pre-manufacture messenger RNAs and hold them in reserve until the precise moment their protein products are needed.

Nuclear speckles, also called interchromatin granule clusters, are dense assemblies of splicing factors and other RNA-processing proteins that punctuate the nucleoplasm. For decades they have been viewed primarily as storage and recycling depots for the molecular machinery that removes introns. The new work adds an unexpected twist: the periphery of these speckles, the thin shell of material surrounding each cluster, functions as a dedicated holding zone for a specific and functionally coherent set of long-lived intron-retained RNAs. The RNAs are not inside the speckles themselves but accumulate in a defined rim around them, suggesting that the boundary between the speckle interior and the surrounding nucleoplasm is an active regulatory interface rather than a passive border.

To reach this conclusion, the team combined super-resolution imaging with single-molecule RNA detection methods, allowing them to see precisely where individual RNA molecules reside relative to speckle markers. They complemented these spatial maps with metabolic labeling approaches that reveal RNA age, showing that the transcripts parked at the speckle periphery are remarkably stable, persisting far longer than typical messenger RNAs, which are usually made, used and degraded within hours. This longevity is a key feature of the compartment: it enables the cell to accumulate a ready supply of transcripts whose final activation can be deferred.

What makes the discovery particularly striking is the identity of the genes whose RNAs are stored in this way. The researchers found that the pooled intron-retained transcripts are disproportionately derived from genes involved in cell cycle regulation and genome maintenance, the very processes a cell must coordinate with exquisite timing as it prepares to divide. By retaining an intron, the cell prevents these RNAs from being translated into protein while keeping them intact and available. The speckle periphery thus acts as a staging ground where the molecular instructions for division and DNA repair are held in check until the proper moment.

That moment, the study shows, arrives at mitosis. When a cell commits to division, its nuclear envelope breaks down, chromosomes condense, and the ordinary architecture of the nucleus dissolves. The researchers observed that the intron-retained RNAs accumulated at the speckle periphery undergo synchronous splicing during this transition, with the retained introns removed en masse as the cell divides. In other words, the entire stockpile is resolved at once, releasing a coordinated wave of newly matured messenger RNAs precisely when the cell reorganizes its contents and re-establishes gene expression in two daughter cells. This synchronized resolution suggests a mechanism by which cells couple RNA maturation directly to the physical events of division.

The finding reframes intron retention from a curiosity of RNA biology into a temporally precise control point. In many previous studies, intron-retained transcripts were viewed mainly as substrates for surveillance pathways that degrade defective RNAs. The new evidence indicates that at least a substantial fraction of retained transcripts are instead functional intermediates, deliberately produced and stored. Their sequestration at the speckle periphery provides a physical address that separates them from the translation machinery and from the splicing factors that would otherwise complete their maturation, while keeping them close to the very machinery they will eventually need.

The spatial logic of the system is as important as the temporal one. By concentrating related RNAs in a shared compartment, the cell may achieve coordination that would be difficult to accomplish with freely diffusing molecules. Grouping cell cycle and genome maintenance transcripts at the speckle rim could allow a single regulatory event, such as the reactivation of splicing during mitosis, to act on many genes simultaneously, ensuring that their protein products appear together rather than in a stochastic trickle. This kind of collective behavior echoes themes familiar from other membrane-less organelles, where concentrated molecules can switch states rapidly in response to cellular cues.

The work also raises new questions that the field is now poised to explore. What molecular signals mark particular intron-retained RNAs for delivery to the speckle periphery, and what prevents their premature splicing during interphase? How is the compartment disassembled and reassembled across successive rounds of the cell cycle, and does the synchronous splicing at mitosis depend on the wholesale reorganization of the nucleus or on dedicated regulatory factors? Answers to these questions could illuminate how cells safeguard the fidelity of division, and how that safeguarding fails in diseases such as cancer, where both splicing patterns and cell cycle control are frequently disrupted.

For now, the study stands as a vivid demonstration that the nucleus is organized with far more purpose than a bag of freely mixing parts. At the edge of each nuclear speckle, cells maintain a carefully curated archive of unfinished messages, genes for division and genome care held in a long-lived, spatially defined waiting room. When mitosis arrives, the doors open all at once, and the archive is converted, in a single synchronized act of splicing, into the working instructions for building two new cells.

Subject of Research: Spatial and temporal regulation of long-lived intron-retained RNAs at nuclear speckle peripheries and their synchronous splicing during mitosis

Article Title: The periphery of nuclear speckles defines a spatially and temporally regulated compartment of long-lived intron-retained RNAs that resolves during mitosis

Article References: Biayna, J., Baranovskii, A., Chaudhuri, A., Paladin, M., Erdem, B., Keller, L.-E., Barutcu, A. R., Dimmeler, S., Marsico, A., & Dumbović, G. (2026). The periphery of nuclear speckles defines a spatially and temporally regulated compartment of long-lived intron-retained RNAs that resolves during mitosis. Nature Cell Biology, 28(9), 1857-1874. https://doi.org/10.1038/s41556-026-02040-5

Image Credits: AI Generated

DOI: 10.1038/s41556-026-02040-5

Keywords: nuclear speckles, intron retention, RNA splicing, mitosis, cell cycle, genome maintenance, RNA processing, nuclear organization, long-lived RNAs, speckle periphery, gene expression, Nature Cell Biology